KIR genotype is associated with progression-free and overall survival following autologous stem cell transplantation for multiple myeloma

被引：0
|
作者：
Gabriel, I. [1 ]
Sargent, R. [1 ]
De Lavallade, H. [1 ]
Szydlo, R. [1 ]
Apperley, J. [1 ]
Khoder, A. [1 ]
Alsuliman, A. [1 ]
Marin, D. [1 ]
Foroni, L. [1 ]
Davis, J. [1 ]
Giles, C. [1 ]
Kanfer, E. [1 ]
Rahemtulla, A. [1 ]
Rezvani, K. [1 ]
机构：
[1] Imperial Coll NHS Trust, London, England
来源：
BONE MARROW TRANSPLANTATION | 2010年 / 45卷
关键词：
D O I：
暂无
中图分类号：
Q6 [生物物理学];
学科分类号：
071011 ;
摘要：
引用
收藏
页码：S148 / S149
页数：2
相关论文
共 50 条
  • [21] Interaction between KIR3DS1 and HLA-Bw4 predicts for progression-free survival after autologous stem cell transplantation in patients with multiple myeloma
    Gabriel, Ian H.
    Sergeant, Ruhena
    Szydlo, Richard
    Apperley, Jane F.
    deLavallade, Hugues
    Alsuliman, Abdullah
    Khoder, Ahmad
    Marin, David
    Kanfer, Edward
    Cooper, Nichola
    Davis, John
    MacDonald, Donald
    Bua, Marco
    Foroni, Letizia
    Giles, Chrissy
    Milojkovic, Dragana
    Rahemtulla, Amin
    Rezvani, Katayoun
    [J]. BLOOD, 2010, 116 (12) : 2033 - 2039
  • [22] Identification of Immune Phenotypes Associated with Improved Progression Free and Overall Survival for Patients with Multiple Myeloma Treated with Autologous Hematopoietic Cell Transplantation
    Ho, Christine M.
    Hahn, Theresa
    Wallace, Paul K.
    Zhang, Yali
    Fora, Ahmad
    Chen, George L.
    Holstein, Sarah A.
    Mellors, Patrick
    McCarthy, Benjamin
    Balderman, Sophia R.
    McCarthy, Philip L.
    [J]. BLOOD, 2016, 128 (22)
  • [23] Upgrade Of FDG-PET Response Following Autologous Stem Cell Transplantation Is Associated With Better Progression Free Survival Among Patients With Multiple Myeloma
    Beksac, M.
    Topcuoglu, P.
    Gunduz, M.
    Ataca, P.
    Ozturk, S. M. Bakanay
    Kirazli, B.
    Merter, M.
    Ozen, M.
    Kucuk, N. O.
    Ozkan, E.
    [J]. BONE MARROW TRANSPLANTATION, 2015, 50 : S18 - S19
  • [24] Impact of Duration of Induction Therapy on Progression-Free Survival in Patients with Newly Diagnosed Multiple Myeloma Undergoing Upfront Autologous Stem Cell Transplantation
    Chakraborty, Rajshekar
    Muchtar, Eli
    Kumar, Shaji K.
    Buadi, Francis K.
    Dingli, David
    Dispenzieri, Angela
    Haymann, Suzanne
    Hogan, William J.
    Kapoor, Prashant
    Lacy, Martha Q.
    Leung, Nelson
    Warsame, Rahma
    Kourelis, Taxiarchis
    Gonsalves, Wilson I.
    Gertz, Morie A.
    [J]. BLOOD, 2017, 130
  • [25] NO EVIDENCE FOR IMPROVED OVERALL SURVIVAL OR PROGRESSION-FREE SURVIVAL IN MULTIPLE MYELOMA PATIENTS AGED 70-75 UNDERGOING AUTOLOGOUS STEM CELL TRANSPLANTATION COMPARED TO A NON-TRANSPLANT STRATEGY
    Riva, Eloisa
    Kastritis, Efsthathios
    Gras, Luuk
    Koster, Linda
    Caillot, Denis
    Tucci, Alessandra
    Lanza, Francesco
    Musso, Maurizio
    Sirvent, Anne
    Illes, Arpad
    Ram, Ron
    Bonifazi, Francesca
    Bourhis, Jean Henri
    Zuckerman, Tsila
    Mizuno, Shohei
    Roussou, Maria
    Dimopoulos, Meletios A.
    Mian, Hira S.
    Atsuta, Yoshiko
    Snowden, John
    Sureda, Anna
    Aljurf, Mahmoud
    de Wreede, Liesbeth C.
    Hayden, Patrick J.
    McLornan, Donal
    Niederwieser, Dietger
    Garderet, Laurent
    [J]. BONE MARROW TRANSPLANTATION, 2023, 58 (SUPP1) : 366 - 367
  • [26] Severe Infections and Antibiotic Use Negatively Impact Progression Free and Overall Survival of Multiple Myeloma Patients Undergoing Autologous Stem Cell Transplantation
    McKenna, Marshall
    Feinman, Rena
    Ahn, Jaeil
    Wang, Shuqi
    Paleoudis, Elli Gourna
    Vesole, David H.
    Goldberg, Stuart L.
    Wang, Jun Chih
    Rehman, Abdul
    Suero-Abreu, Giselle Alexandra
    McKiernan, Phyllis
    Donato, Michele L.
    Rowley, Scott D.
    Siegel, David S.
    Biran, Noa
    [J]. BLOOD, 2019, 134
  • [27] KIR genes are associated with incidence and duration of infection following autologous peripheral blood stem cell transplantation for multiple myeloma
    Gabriel, I. H.
    Ibrahim, M.
    Szydlo, R.
    de Lavallade, H.
    Apperley, J. F.
    Thomas, C.
    Kanfer, E.
    Marin, D.
    Doyle, A.
    Rahemtulla, A.
    Rezvani, K.
    [J]. BRITISH JOURNAL OF HAEMATOLOGY, 2010, 149 : 68 - 68
  • [28] KIR genes are associated with incidence and duration of infection following autologous peripheral blood stem cell transplantation for multiple myeloma
    Ibrahim, M.
    Gabriel, I.
    Szydlo, R.
    De Lavallade, H.
    Apperley, J.
    Thomas, C. P.
    Kanfer, E.
    Doyle, A.
    Rahemtulla, A.
    Rezvani, K.
    [J]. BONE MARROW TRANSPLANTATION, 2010, 45 : S21 - S21
  • [29] Autologous stem cell transplantation in first remission significantly prolongs progression-free and overall survival in mantle-cell lymphoma (MCL)
    Dreyling, M.
    Zoellner, A. -K.
    Stilgenbauer, S.
    Huebel, K.
    Thieblemont, C.
    Metzner, B.
    Kluin-Nelemans, H.
    Hiddemann, W.
    Unterhalt, M.
    Hoster, E.
    [J]. ONCOLOGY RESEARCH AND TREATMENT, 2019, 42 : 186 - 186
  • [30] XRCC1-mediated DNA repair is associated with progression-free survival of multiple myeloma patients after autologous stem cell transplant
    Persaud, Avinash K.
    Li, Junan
    Johnson, Jasmine A.
    Seligson, Nathan
    Sborov, Douglas W.
    Duah, Ernest
    Cho, Yu Kyoung
    Wang, Danxin
    Phelps, Mitch A.
    Hofmeister, Craig C.
    Poi, Ming J.
    [J]. MOLECULAR CARCINOGENESIS, 2019, 58 (12) : 2327 - 2339
12345